Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes

Maham Hayat1 Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA, [email protected]Correspondence[email protected]

Hassaan Zia2 Section of Digestive Diseases & Nutrition, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

Salman Nusrat2 Section of Digestive Diseases & Nutrition, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

Pages 43-47 | Published online: 12 Feb 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

HerrickLMSpaldingWMSaitoYAMoriartyJSchleckCA case–control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohortJ Med Econ201720327327927783533
PubMed Web of Science ®Google Scholar
MartinBCBarghoutVCerulliADirect medical costs of constipation in the United StatesManag Care Interface200619124349
Google Scholar
SuaresNCFordACPrevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysisAm J Gastroenterol20111069158291 quiz 1581, 159221606976
PubMed Web of Science ®Google Scholar
DiazSMendezMDConstipationTreasure Island (FL)StatPearls Publishing LLC2018
Google Scholar
FordACMoayyediPLacyBEAmerican College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipationAm J Gastroenterol2014109Suppl 1S2S26 quiz S2725091148
PubMed Web of Science ®Google Scholar
JohansonJFKralsteinJChronic constipation: a survey of the patient perspectiveAliment Pharmacol Ther200725559960817305761
PubMed Web of Science ®Google Scholar
TalleyNJWeaverALZinsmeisterARMeltonLJ3rdOnset and disappearance of gastrointestinal symptoms and functional gastrointestinal disordersAm J Epidemiol199213621651771415139
PubMed Web of Science ®Google Scholar
LemboACamilleriMChronic constipationN Engl J Med2003349141360136814523145
PubMed Web of Science ®Google Scholar
LawMFHoRCheungCKPrevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapyWorld J Gastroenterol201622286484650027605883
PubMed Web of Science ®Google Scholar
LangLThe Food and Drug Administration approves lubiprostone for irritable bowel syndrome with constipationGastroenterology200813517
Web of Science ®Google Scholar
LoombaRRowleyAWesleyRSystematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapyAnn Intern Med2008148751952818378948
PubMed Web of Science ®Google Scholar
LacyBELevyLCLubiprostone: a chloride channel activatorJ Clin Gastroenterol200741434535117413599
PubMed Web of Science ®Google Scholar
BarishCFDrossmanDJohansonJFUenoREfficacy and safety of lubiprostone in patients with chronic constipationDig Dis Sci20105541090109720012484
PubMed Web of Science ®Google Scholar
JohansonJFUenoRLubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safetyAliment Pharmacol Ther200725111351136117509103
PubMed Web of Science ®Google Scholar
JohansonJFMortonDGeenenJUenoRMulticenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipationAm J Gastroenterol2008103117017717916109
PubMed Web of Science ®Google Scholar
FukudoSHongoMKanekoHTakanoMUenoRLubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipationClin Gastroenterol Hepatol2015132294301.e525158925
PubMed Web of Science ®Google Scholar
FukudoSHongoMKanekoHUenoREfficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding studyNeurogastroenterol Motil2011236544e20521303430
PubMed Web of Science ®Google Scholar
FordACSuaresNCEffect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysisGut201160220921821205879
PubMed Web of Science ®Google Scholar
HuangHTaylorDCCarsonRTEconomic evaluation of linaclotide for the treatment of adult patients with chronic idiopathic constipation in the United StatesManag Care20162524148
Google Scholar
LiFFuTTongWDLubiprostone is effective in the treatment of chronic idiopathic constipation and irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trialsMayo Clin Proc201691445646827046523
PubMed Web of Science ®Google Scholar
CryerBDrossmanDACheyWDWebsterLHabibiSWangMAnalysis of nausea in clinical studies of lubiprostone for the treatment of constipation disordersDig Dis Sci201762123568357828849329
PubMed Web of Science ®Google Scholar
JohansonJFDrossmanDAPanasRWahleAUenoRClinical trial: Phase 2 study of lubiprostone for irritable bowel syndrome with constipationAliment Pharmacol Ther200827868569618248656
PubMed Web of Science ®Google Scholar
DrossmanDACheyWDJohansonJFClinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome – results of two randomized, placebo-controlled studiesAliment Pharmacol Ther200929332934119006537
PubMed Web of Science ®Google Scholar
PenningtonBMarriottERLichtlenPAkbarAHatswellAJThe cost effectiveness of lubiprostone in chronic idiopathic constipationPharmacoecon Open20182324125329302926
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date